A look at medical outposts
Article 58, a process introduced by the European Commission to help speed up the time low and middle-income countries take to approve new drugs, could be in for a massive overhaul. A revamp has been proposed because it is underused – just a handful of products have gone through the Article 58 process since its … Continue reading IP Watch: EU Eyes Revamp Of Policy To Speed Drug Approvals In Developing countries
Governments are considering which financial incentives will be the best to boost research and development for much needed new antibiotic drugs. Tatum Anderson reports in The Lancet.
International Travel Insurance journal; the lack of parity between mental and physical health insurance coverage.